Operating profit before amortization: opgen.com (OPGN)

Brandmark of OpGen Inc (OPGN)

OpGen, Inc. (OPGN) faces a liquidity shortage and the threat of delisting, yet GURU.Markets quotes shape this chart, where the actual size of operating profit via records a new level. The company is developing an express diagnostic system for antibiotic resistance for hospitals, while operational processes are strictly limited by FDA medical regulations regarding the disposal of biomaterials.

OPGN: OpGen Operating profit EBITDA 07/04/2022 - 11/10/2026

OpGen - analytical breakdowns and key metrics (OPGN)

- stock value and consensus price forecast:
Market Chart OpGen Corporation|OPGN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization OpGen|OPGN - Enterprise Value
- balance sheet net asset value indicators:
Share Book Value OpGen|OPGN - Book Capitalization|Market-to-Book Ratio opgen.com|OPGN - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio OpGen, Inc.|OPGN - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio OpGen Inc|OPGN - Company Aggregate Debts|Debts to Net Assets OpGen|OPGN - Company Long-Term Debt|Short-Term Debt OpGen|Immediate Liquidity Ratio opgen.com
- earnings and valuation multiples information:
OPGN - Company Net Income|Company Profit Forecast OpGen, Inc.|OPGN - Price to Earnings Ratio|Projected Price to Earnings Ratio opgen.com|OPGN - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio OpGen|OPGN - Operating profit EBITDA|Net earnings per share for the trailing year OpGen|OPGN - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months opgen.com|OPGN - Earnings per share growth in current year|Projected earnings per share growth rate for next year OpGen, Inc.
Summary company analytics:OPGN OpGen Corporation
Mass-produced product of opgen.com

This indicator is calculated as the difference between revenue and operating expenses, excluding depreciation, which allows for the determination of actual cash flow from core operations and the identification of trend reversal points in profitability. For OpGen, Inc. (OPGN), which is actively investing in AI platforms and DNA tests, current cash operating profit serves as a metric for the efficiency of R&D commercialization and the sustainability of the business model.

Competitors of OpGen, Inc. (OPGN)

Operating income before deduction of amortization Summit Pharma (SMMT)|MRNA - Profit before payment of interest, taxes and amortization|PCVX (vaxcyte.com) - Operating profit before amortization|TARS: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization CRMD (CorMedix Inc)|MCRB (Seres) - Operating profit EBITDA|Profit before interest, taxes and amortization Spero Pharma SPRO|Operating profit EBITDA SCYX|Operating profit before deduction of amortization an2therapeutics.com ANTX|PolyPid - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization LSB (LakeShore Biopharma Co., Ltd.)|Iterum Therapeutics, plc - Operating profit EBITDA|Operating income before deduction of amortization BiomX Inc. PHGE|soligenix.com (SNGX) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization 60 Degrees Pharmaceuticals, Inc. (SXTP)|Profit before payment of interest, taxes and amortization Oragenics